Type 2 Diabetes Study – Seeking Volunteers Who Treat with Any Combination of Medications, Except Insulin.

  • STATUS
    Recruiting
Updated on 22 April 2021

Summary

We are currently seeking volunteers who are diagnosed with Type 2 Diabetes and who are treating with any combination of medications including any of the following:
  • Metformin
  • Sulfonylureas (Glyburide, Glipizide, or Glimepiride.)
  • Glinides (Prandin or Starlix.)
  • DPP-4 inhibitors (Januvia, Onglyza, Tradjenta, or Nesina.)
  • SLGT-2 inhibitors (Farxiga, Invokana, or Jardiance.)
  • TZDs (Avandia, Actos, or Rezulin.)
  • Alpha-glucosidase inhibitors (Precose, Glyset, or Voglibose.)
  • Oral or injectable GLP-1 RAs (Byetta, Bydureon, Victoza, Trulicity, Tanzeum, Ozempic, or Rybelsus-[oral].) 

 This is a study of an investigational once weekly basal insulin, that may help improve blood sugar level control. Participants will be assigned to one of two groups: half of all participants will take the investigational insulin once a week and a once daily placebo, the other half will take a placebo once a week and Tresiba daily. 

Participants taking Sulfonylureas (Glyburide, Glipizide, Glimepiride) and Glinides (Prandin or Starlix) will stop taking them. Participants will continue taking their other diabetes medications. Participants must be willing to check their blood sugars at least once a day. 
 
Also, they must be willing to wear a blinded Dexcom G6 continuous glucose monitor on their arms on 4 separate occasions during the study.

Please contact us for further details by filling out this volunteer form below or calling us at 425-251-1720.

Description

Study Length: 32 weeks, with 13 clinic visits, and 17 telephone visits.

Target Age: 18+ years old.

Benefits: Study medication, study related physical exams, EKG’s, eye exams, lab work, a glucose meter, test strips and other supplies.

Stipend:
$1075 for study completion.

Details
Condition Diabetes Mellitus Type 2
Clinical Study IdentifierTX271678
Last Modified on22 April 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Must have been diagnosed with Type 2 Diabetes for ≥ 180 days
Must have an HbA1c between 7.0 - 11.0%
Must be treating with any combination of medications including any of the following
Metformin
Sulfonylureas (Glyburide, Glipizide, or Glimepiride.)
Glinides (Prandin or Starlix.)
DPP-4 inhibitors (Januvia, Onglyza, Tradjenta, or Nesina.)
SLGT-2 inhibitors (Farxiga, Invokana, or Jardiance.)
TZDs (Avandia, Actos, or Rezulin.)
Alpha-glucosidase inhibitors (Precose, Glyset, or Voglibose.)
Oral or injectable GLP-1 RAs (Byetta, Bydureon, Victoza, Trulicity, Tanzeum, Ozempic, or Rybelsus-[oral].)
Must meet other eligibility criteria
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note